Spots Global Cancer Trial Database for china
Every month we try and update this database with for china cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM) | NCT01300689 | HPV Infection HIV Infection Syphilis | 18 Years - | ChineseAMS | ||
Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease | NCT02499783 | Crohn's Disease | adalimumab placebo | 18 Years - 70 Years | AbbVie | |
Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors | NCT06276309 | Neuroendocrine ... China Women Cervical Cancer Cervical Lesion | - | Fujian Maternity and Child Health Hospital | ||
10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid Malignancies | NCT00997945 | Advanced Solid ... | ZD4054 (Ziboten... | 50 Years - | AstraZeneca | |
Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection | NCT04666272 | Melanoma | dabrafenib trametinib | 18 Years - 100 Years | Novartis | |
A National Registry on Chinese Patients With Lymphangioleiomyomatosis | NCT03193892 | Pulmonary Funct... | - | Peking Union Medical College Hospital | ||
Identifying MSI Status From ctDNA in Chinese Patients With Refractory Advanced Solid Tumors | NCT03596593 | Solid Tumor | SPANOM (identif... | 18 Years - | Peking University | |
Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection | NCT04666272 | Melanoma | dabrafenib trametinib | 18 Years - 100 Years | Novartis | |
A Study to Assess Safety of Nivolumab in Routine Oncology Practice in China | NCT04825873 | Non-Small Cell ... Squamous Cell C... | 18 Years - | Bristol-Myers Squibb | ||
A Study to Determine the Pharmacokinetics of Cediranib in Chinese Patients With Advanced Solid Malignancies | NCT00981721 | Advanced Solid ... | cediranib (RECE... | 18 Years - | AstraZeneca | |
Financial Incentives and Motivational Intervention to Improve Gastric Cancer Screening in China | NCT06384300 | Gastric Cancer | Financial Incen... Motivational In... Mixed Intervent... | 40 Years - 80 Years | Peking University | |
China Lymphoma Patient Registry Study | NCT03313271 | Lymphoma | 18 Years - | Peking University | ||
Efficacy of Endoscopy Screening on Esophageal Cancer in China (ESECC) | NCT01688908 | Esophageal Squa... Dysplasia | Endoscopic Scre... | 45 Years - 69 Years | Peking University | |
Genes Involved in Resistance or Susceptibility to Hepatitis B Virus | NCT00342186 | Hepatitis, Vira... | 8 Years - 90 Years | National Institutes of Health Clinical Center (CC) | ||
Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM) | NCT01300689 | HPV Infection HIV Infection Syphilis | 18 Years - | ChineseAMS | ||
Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection | NCT04666272 | Melanoma | dabrafenib trametinib | 18 Years - 100 Years | Novartis | |
Melatonin and Risk Of Cardiovascular Events And Malignant Tumors In The Elderly | NCT04631341 | Cardiovascular ... | Melatonin | 60 Years - 74 Years | RenJi Hospital | |
Efficacy of Endoscopy Screening on Esophageal Cancer in China (ESECC) | NCT01688908 | Esophageal Squa... Dysplasia | Endoscopic Scre... | 45 Years - 69 Years | Peking University | |
TreAtments and outComes in paTients With prImary CutAneous Lymphoma | NCT05518851 | Primary Cutaneo... | - | Peking University First Hospital | ||
Genes Involved in Resistance or Susceptibility to Hepatitis B Virus | NCT00342186 | Hepatitis, Vira... | 8 Years - 90 Years | National Institutes of Health Clinical Center (CC) |